<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic>	<https://research.tib.eu/covid-19/entity/Homosalate%2080%20mg%20in%201%20ml%20/%20octinoxate%2075%20mg%20in%201%20ml%20/%20octisalate%2050%20mg%20in%201%20ml%20/%20oxybenzone%2050%20mg%20in%201%20ml%20/%20avobenzone%2030%20mg%20in%201%20ml%20topical%20lotion%20%5Bmark.%20for%20gooness%20face%20antioxidant%20skin%20moisturizing%5D>
<http://xmlns.com/foaf/0.1/topic>	Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>	<https://research.tib.eu/covid-19/data/entity/Homosalate%2080%20mg%20in%201%20ml%20/%20octinoxate%2075%20mg%20in%201%20ml%20/%20octisalate%2050%20mg%20in%201%20ml%20/%20oxybenzone%2050%20mg%20in%201%20ml%20/%20avobenzone%2030%20mg%20in%201%20ml%20topical%20lotion%20%5Bmark.%20for%20gooness%20face%20antioxidant%20skin%20moisturizing%5D>
<http://purl.org/net/provenance/ns#createdBy>	Anon_1   (more) <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataCreation> <http://purl.org/net/provenance/ns#performedAt> 2024-12-01T20:39:16.072Z <http://purl.org/net/provenance/ns#performedBy> Anon_2   (more) <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataProvidingService> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#Actor> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/types#DataCreatingService> <http://purl.org/net/provenance/ns#deployedSoftware> Anon_3   (more) <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://usefulinc.com/ns/doap#Version> <http://usefulinc.com/ns/doap#revision> 0.4 <http://www.w3.org/2000/01/rdf-schema#seeAlso> <https://research.tib.eu/covid-19/> <http://purl.org/net/provenance/ns#usedData> Anon_4   (more) <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/types#QueryResult> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph> <http://purl.org/net/provenance/ns#retrievedBy> Anon_5   (more) <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataAccess> <http://purl.org/net/provenance/ns#performedAt> 2024-12-01T20:39:16.072Z <http://purl.org/net/provenance/ns#performedBy> Anon_2   (more) <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataProvidingService> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#Actor> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/types#DataCreatingService> <http://purl.org/net/provenance/ns#deployedSoftware> Anon_3   (more) <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://usefulinc.com/ns/doap#Version> <http://usefulinc.com/ns/doap#revision> 0.4 <http://www.w3.org/2000/01/rdf-schema#seeAlso> <https://research.tib.eu/covid-19/> <http://purl.org/net/provenance/ns#accessedService> <https://labs.tib.eu/sdm/covid19kg/sparql>   (more) <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#Actor> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/types#DataCreatingService> <http://purl.org/net/provenance/ns#createdBy> Anon_6   (more) <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataCreation> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/types#QueryExecution> <http://purl.org/net/provenance/ns#performedBy> <https://labs.tib.eu/sdm/covid19kg/sparql>   (more) <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#Actor> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/types#DataCreatingService> <http://purl.org/net/provenance/ns#usedGuideline> Anon_7   (more) <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/types#SPARQLQuery> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://spinrdf.org/sp#Describe> <http://www.w3.org/2000/01/rdf-schema#label> DESCRIBE <http://research.tib.eu/covid-19/entity/Homosalate%2080%20mg%20in%201%20ml%20/%20octinoxate%2075%20mg%20in%201%20ml%20/%20octisalate%2050%20mg%20in%201%20ml%20/%20oxybenzone%2050%20mg%20in%201%20ml%20/%20avobenzone%2030%20mg%20in%201%20ml%20topical%20lotion%20%5Bmark.%20for%20gooness%20face%20antioxidant%20skin%20moisturizing%5D>

This page shows information obtained from the SPARQL endpoint at https://labs.tib.eu/sdm/covid19kg/sparql.
As Turtle | As RDF/XML | Browse in Disco | Browse in Tabulator | Browse in OpenLink Browser